C13H23BN2O3
Neat
266.15
1029716-44-6; 1-(1-Ethoxyethyl)-4-(4, 4, 5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl)-1H-pyrazole; DTXSID30673882; RefChem:222473; DTXCID70624631; 1-(1-Ethoxyethyl)-1H-pyrazole-4-boronic acid pinacol ester; MFCD11857753; 1-(1-ethoxyethyl)-4-(4, 4, 5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl)pyrazole; 1-(1-ethoxyethyl)-4-(tetramethyl-1, 3, 2-dioxaborolan-2-yl)-1H-pyrazole; (1-(1-ETHOXYETHYL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER; 1H-Pyrazole, 1-(1-ethoxyethyl)-4-(4, 4, 5, 5-tetramethyl-1, 3, 2-dioxaborolan-2-yl)-; 1-(1-Ethoxyethyl)-4-(4, 4, 5, 5-tetramethyl-1, 3 and 2-dioxaborolan-2-yl)-1H-pyrazole;; Baricitinib Impurity 14; SCHEMBL872483; IZKVGEWCELXYRI-UHFFFAOYSA-N; B3622LE5H9; CS-M1565; AKOS015838747; SB12197; AC-30031
1-(1-ethoxyethyl)-4-(4, 4, 5, 5-tetramethyl-1, 3 and 2-dioxaborolan-2-yl)pyrazole
InChI=1S/C13H23BN2O3/c1-7-17-10(2)16-9-11(8-15-16)14-18-12(3,4)13(5,6)19-14/h8-10H,7H2,1-6H3